AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimgos M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Segos Biocare

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimgos M 1mg/500mg Tablet SR

Diabetic patients using Glimgos M 1mg/500mg SR tablets, an anti-diabetic combination medication, should adhere to their prescribed dosage. This dual-action drug manages blood glucose in adult type 2 diabetics. Consistent daily intake, ideally with meals, maximizes efficacy. Dosage adjustments, based on blood sugar monitoring and physician assessment, may occur. Discontinuing Glimgos M without medical guidance risks elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication is a component of a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your healthcare provider. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are crucial preventative measures. Alcohol consumption should be minimized due to its hypoglycemic effect. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain is also possible. Glimgos M is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Pre-existing heart conditions, pregnancy, or breastfeeding necessitate physician consultation prior to initiating treatment. Routine blood glucose checks and periodic blood tests (blood cell counts, liver function) are typically recommended.

Uses of Glimgos M 1mg/500mg Tablet SR

Managing Type 2 diabetes

Major Benefits of Glimgos M 1mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Glimgos M 1mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing it. It should be administered with food.

Common Side effects of Glimgos M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimgos M 1mg/500mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Consume Glimgos M 1mg/500mg Sustained-Release tablets with food.

How Glimgos M 1mg/500mg Tablet SR works:

Glimgos M 1mg/500mg Extended-Release tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while taking Glimigos M 1mg/500mg SR tablets.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glimgos M 1mg/500mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to any prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimgos M tablets (1mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimgos M 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is recommended. This medication is contraindicated in individuals with severe kidney disease. Routine monitoring of kidney function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimgos M 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, a low starting dose is typical; however, its use is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glimgos M 1mg/500mg Tablet SR :

Should you forget to take a Glimgos M 1mg/500mg Tablet SR, ingest it promptly upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid doubling the prescribed amount.

Facts to Know About Glimgos M 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Glimgos M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimgos M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glimgos M 1mg/500mg Tablet SR and seek immediate medical attention.
Glimgos M 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimgos M 1mg/500mg Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glimigos M 1mg/500mg SR tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimgos M 1mg/500mg SR Tablets can induce hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimgos M 1mg/500mg SR tablets with alcohol is unsafe. Alcohol can lower blood sugar, increasing the risk of hypoglycemia and lactic acidosis.
Glimgos M 1mg/500mg Table...
37
MRP 45
17% off